…
Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients in the Netherlands, the United States, Latin America, Asia, rest of North America, and rest of Europe, the Middle East, and Africa. The company offers ingredient solutions made from renewable resources for the food, home and personal care, animal nutrition, pharmaceutical, medical device, and bioplastics markets It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 116.40M | 86.50M | 87.70M | 44.70M | 69.80M |
| Minority interest | - | - | - | 0.00M | 0.00M |
| Net income | 90.00M | 78.30M | 73.10M | 25.80M | 54.30M |
| Selling general administrative | 92.40M | 85.50M | 79.90M | 79.10M | 69.30M |
| Selling and marketing expenses | 81.10M | 67.50M | 62.70M | 67.90M | 61.40M |
| Gross profit | 324.30M | 265.80M | 269.80M | 233.70M | 258.00M |
| Reconciled depreciation | 76.40M | 64.10M | 60.30M | 61.50M | 42.00M |
| Ebit | 123.90M | 65.00M | 101.40M | 58.90M | 82.50M |
| Ebitda | 200.30M | 129.10M | 161.70M | 120.40M | 124.50M |
| Depreciation and amortization | 76.40M | 64.10M | 60.30M | 61.50M | 42.00M |
| Non operating income net other | - | - | - | 0.00M | 0.00M |
| Operating income | 110.80M | 82.00M | 104.10M | 61.30M | 87.90M |
| Other operating expenses | 1354.30M | 1023.80M | 882.40M | 915.10M | 809.30M |
| Interest expense | 17.00M | 13.70M | 13.70M | 14.20M | 12.70M |
| Tax provision | 26.40M | 8.20M | 14.60M | 18.90M | 15.50M |
| Interest income | 3.40M | 4.40M | 2.90M | 3.80M | 3.10M |
| Net interest income | -14.40M | -8.90M | -11.10M | -10.60M | -10.40M |
| Extraordinary items | - | - | - | 0.00M | 0.00M |
| Non recurring | - | - | - | 0.00M | 0.00M |
| Other items | - | - | - | 0.00M | 0.00M |
| Income tax expense | 26.40M | 8.20M | 14.60M | 18.90M | 15.50M |
| Total revenue | 1457.90M | 1070.80M | 986.50M | 976.40M | 897.20M |
| Total operating expenses | 220.70M | 218.80M | 165.70M | 172.40M | 170.10M |
| Cost of revenue | 1133.60M | 805.00M | 716.70M | 742.70M | 639.20M |
| Total other income expense net | 5.60M | 4.50M | -16.40M | -16.60M | -18.10M |
| Discontinued operations | - | - | - | 0.00M | 0.00M |
| Net income from continuing ops | 90.00M | 78.30M | 73.10M | 25.80M | 54.30M |
| Net income applicable to common shares | 90.00M | 78.30M | 73.10M | 25.80M | 54.30M |
| Preferred stock and other adjustments | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1705.40M | 1341.10M | 1074.50M | 1091.10M | 965.80M |
| Intangible assets | 80.10M | 80.20M | 95.60M | 92.50M | 77.90M |
| Other current assets | - | 11.20M | 18.40M | 1.50M | 0.00M |
| Total liab | 1079.70M | 787.00M | 558.50M | 562.00M | 445.60M |
| Total stockholder equity | 625.70M | 554.10M | 516.00M | 529.10M | 520.20M |
| Deferred long term liab | - | 30.70M | 31.40M | 31.50M | 31.60M |
| Other current liab | 122.40M | 108.40M | 83.10M | 73.30M | 55.90M |
| Common stock | 14.80M | 14.80M | 14.80M | 14.80M | 14.80M |
| Capital stock | 14.80M | 14.80M | 14.80M | 14.80M | 14.80M |
| Retained earnings | 493.80M | 430.20M | 403.60M | 367.00M | 379.20M |
| Other liab | 49.80M | 47.40M | 40.20M | 45.40M | 51.50M |
| Good will | 83.50M | 77.70M | 70.10M | 80.40M | 61.30M |
| Other assets | - | 142.10M | 131.40M | 122.50M | 120.50M |
| Cash | 58.20M | 42.20M | 51.60M | 45.70M | 47.10M |
| Total current liabilities | 592.70M | 321.00M | 233.90M | 347.70M | 260.00M |
| Current deferred revenue | 118.90M | - | - | - | 6.70M |
| Net debt | 701.00M | 461.00M | 284.20M | 303.30M | 203.20M |
| Short term debt | 322.00M | 84.60M | 51.40M | 180.10M | 116.30M |
| Short long term debt | 309.70M | 74.70M | 42.40M | 169.80M | 165.40M |
| Short long term debt total | 759.20M | 503.20M | 335.80M | 349.00M | 250.30M |
| Other stockholder equity | 117.10M | 109.10M | 97.60M | 147.30M | 126.20M |
| Property plant equipment | 729.50M | 532.90M | 406.50M | 433.00M | 368.90M |
| Total current assets | 654.30M | 504.50M | 385.10M | 372.50M | 349.60M |
| Long term investments | - | - | - | 263.08M | 75.71M |
| Net tangible assets | - | 426.90M | 381.70M | 387.70M | 412.60M |
| Short term investments | - | - | - | 0.00M | 0.00M |
| Net receivables | 210.50M | 212.40M | 143.80M | 155.00M | 144.40M |
| Long term debt | 376.00M | 359.10M | 239.50M | 113.00M | 159.90M |
| Inventory | 331.20M | 230.00M | 164.80M | 163.20M | 152.70M |
| Accounts payable | 148.30M | 128.00M | 99.40M | 94.30M | 87.80M |
| Total permanent equity | - | - | - | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | 0.00M | 0.00M |
| Accumulated other comprehensive income | - | - | - | 0.00M | 0.00M |
| Additional paid in capital | - | - | - | 0.00M | 0.00M |
| Common stock total equity | - | - | - | 0.00M | 0.00M |
| Preferred stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | 0.00M | 0.00M |
| Treasury stock | - | - | - | 0.00M | 0.00M |
| Accumulated amortization | - | - | - | 0.00M | 0.00M |
| Non currrent assets other | 127.40M | 118.50M | 104.10M | 102.00M | 85.50M |
| Deferred long term asset charges | - | - | - | 0.00M | 0.00M |
| Non current assets total | 1051.10M | 836.60M | 689.40M | 718.60M | 616.20M |
| Capital lease obligations | 73.50M | 69.40M | 53.90M | 66.20M | 1.20M |
| Long term debt total | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -199.10M | 5.50M | 7.50M | -1.40M | -29.30M |
| Change to liabilities | 14.60M | 25.70M | 13.50M | 4.90M | 9.50M |
| Total cashflows from investing activities | -199.10M | -119.40M | -76.90M | -104.80M | -87.60M |
| Net borrowings | 221.80M | 118.90M | 9.10M | 20.90M | 28.60M |
| Total cash from financing activities | 173.90M | 85.90M | -23.90M | -12.00M | -4.30M |
| Change to operating activities | - | -17.90M | -12.10M | -16.60M | 1.10M |
| Net income | 110.80M | 82.00M | 104.10M | 25.80M | 54.30M |
| Change in cash | 16.00M | -9.40M | 5.90M | -1.40M | 9.00M |
| Begin period cash flow | 42.20M | 51.60M | 45.70M | 47.10M | 38.10M |
| End period cash flow | 58.20M | 42.20M | 51.60M | 45.70M | 47.10M |
| Total cash from operating activities | 39.00M | 22.40M | 109.00M | 114.40M | 99.50M |
| Depreciation | 76.40M | 64.10M | 60.30M | 61.50M | 42.00M |
| Other cashflows from investing activities | 14.20M | 4.30M | 4.40M | 1.30M | 1.30M |
| Dividends paid | -33.00M | -33.00M | -33.00M | -32.90M | 32.90M |
| Change to inventory | -90.40M | -54.40M | -17.20M | -3.50M | -15.20M |
| Change to account receivables | -39.00M | -33.20M | -10.70M | -2.60M | -7.20M |
| Sale purchase of stock | - | - | - | 0.00M | 0.00M |
| Other cashflows from financing activities | 209.60M | 121.80M | 135.00M | 30.50M | 41.00M |
| Change to netincome | - | -40.20M | 2.10M | 44.90M | 15.00M |
| Capital expenditures | 235.80M | 148.70M | 88.90M | 76.20M | 60.10M |
| Change receivables | - | - | - | 0.00M | 0.00M |
| Cash flows other operating | - | - | - | 0.00M | 0.00M |
| Exchange rate changes | - | - | - | 0.00M | 0.00M |
| Cash and cash equivalents changes | - | - | - | 0.00M | 0.00M |
| Change in working capital | -110.10M | -86.20M | -27.60M | -17.80M | -13.90M |
| Stock based compensation | 4.80M | 3.50M | 3.90M | 4.00M | 1.60M |
| Other non cash items | -42.90M | -41.00M | -31.70M | 40.90M | 15.50M |
| Free cash flow | -196.80M | -126.30M | 20.10M | 38.20M | 39.40M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CSNVF Corbion N.V |
- -% |
22.17 | 17.10 | 27.93 | 0.82 | 1.81 | 1.38 | 11.06 |
| LIN Linde plc Ordinary Shares |
-7.46 1.46% |
502.75 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.53 1.28% |
40.87 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
-4.87 2.34% |
203.00 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-0.11 0.03% |
339.72 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients in the Netherlands, the United States, Latin America, Asia, rest of North America, and rest of Europe, the Middle East, and Africa. The company offers ingredient solutions made from renewable resources for the food, home and personal care, animal nutrition, pharmaceutical, medical device, and bioplastics markets It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
| Name | Title | Year Born |
|---|---|---|
| Mr. Olivier Rigaud | Chairman of the Management Board & CEO | 1964 |
| Mr. Eddy Van Rhede van Der Kloot | CFO & Member of Management Board | 1963 |
| Ms. Jacqueline van Lemmen | Chief Operations Officer | 1961 |
| Mr. Marcel Wubbolts | Chief Science & Sustainability Officer | 1963 |
| Jeroen van Harten | Director of Investor Relations | NA |
| Tanno Massar | Director of Corp. Communications | NA |
| Ms. Aurelie Dalbiez | Chief HR Officer | 1977 |
| Mr. Andy Muller | Pres of Sustainable Food Solutions | 1965 |
| Mr. Ruud Peerbooms | Pres of Algae Ingredients | 1969 |
| Mr. Marco Bootz | Pres of Lactic Acid & Specialties | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.